You are here: Home > News & Agenda > Agenda

Agenda

EHA 24rd Annual Congress

June 13-16, 2019

Amsterdam, The Netherlands

The EHA Annual Congress is a forum for original unpublished data, for sharing ideas about hematological innovation, as well as for disseminating evidence-based knowledge of primary clinical relevance. Hematologists and affiliated professionals will be able to: Enhance their knowledge of evidence-based approaches to diagnosis and treatment for hematologic diseases. Access the latest results on clinical and translational research in hematologic disorders. Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties. Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.

EHA (European Hematology Association)

Read more

Disease Models & Mechanisms Meeting 2019 ‘Blood disorders: models, mechanisms and therapies’

29 September - 1 October 2019

Boston, USA

Advancing basic research findings to the clinic remains a daunting task. Researchers in the field of hematopoiesis have made significant progress in this regard by taking discoveries from model organisms to the clinic. Such advances, including bone marrow transfers, stem cell replacements and immunotherapies, have also had a large impact on the treatment of non-blood disorders. This meeting on blood disorders and their treatment, organised by the journal Disease Models & Mechanisms, is curated by Editor-in-Chief Monica Justice, Nancy Speck, Paresh Vyas and Leonard Zon. The meeting will bring together diverse front-line researchers, stimulating discussions across basic research and clinical disciplines, and fostering collaborative links among researchers. Talks will feature basic research advances acquired across multiple model organisms, as they are applied to human blood disorders. A primary aim is to promote knowledge of therapies or drug discovery that has been developed pre-clinically to move to a clinical trial. Topics: Blood development: mechanisms and pathology Epigenetic regulation of blood development Erythropoiesis and red cell disorders Targeting blood cancers Clonal hematopoiesis Manipulating the stem cell niche

Monica Justice, Nancy Speck, Paresh Vyas and Leonard Zon

Read more

Copyright © 2002 - 2019 Enerca

Co-funded by the Health Programme of the European Union.